Who are RegCell's investors?

RegCell's investors include Fast Track Initiative, Global Brain, Kyoto University Innovation Capital, UTEC, Mitsubishi UFJ Capital, OSAKA University Venture Capital.

How much funding has RegCell raised?

RegCell has disclosed $45M raised across 1 of its 2 known rounds.

RegCell

7 known investors

Find your way into RegCell

Paths you didn't know you had: your email and LinkedIn already hold routes to the RegCell team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

Biotech Deep Tech Medical Devices

Founders & leadership

Michael McCullar, PhDChief Executive Officer

James AhlersChief Financial Officer

Marty Giedlin, PhDChief Technology Officer

Tony HurleyChief Technical Operations Officer

Steve Kanner, PhDChief Scientific Officer

Investors · 7

Also in the syndicate · 1

Celadon Partners

Funding

SEC filings, press & company announcements

$45M disclosed across 1 of 2 rounds · 2025

Undisclosed amountSeries ASep 2026
Playground Global (lead), Alumni Ventures, Fast Track Initiative, Global Brain, Kyoto University Innovation Capital, LG Technology Ventures, Medical Incubator Japan, Mitsui Chemicals Group, OSAKA University Venture Capital, UTEC
Source ↗
Undisclosed amountseed roundMar 2025
Fast Track Initiative (FTI) (lead), The University of Tokyo Edge Capital Partners (UTEC) (lead), Celadon Partners, Kyoto University Innovation Capital (Kyoto i-Cap), Mitsubishi UFJ Capital, Osaka University Venture Capital (OUVC)
Source ↗
$45MraisedMar 2025 · 4 sources
Fast Track Initiative (FTI) (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Regeneron NASDAQ: REGN www.regeneron.comRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.

Read on Scientific AmericanScientific American is a media organization that publishes research and ideas across science, health, technology and society through multiple formats including print, web, video, and podcasts. Founded in 1845, it reaches over 20 million people monthly and maintains editorial independence while providing trustworthy science communication and commentary.

LyellLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.

Companies working in the same space as RegCell.

In the news

RegCell raises $66m for Treg therapy platformbioxconomy.com · Sep 2026

Fast Track Initative News | FTI Co-Leads USD 45.8 million Investment in RegCell to Accelerate Development of Treg therapy for Autoimmune Diseasesus.fasttrackinitiative.com · Mar 2025

Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition - RegCellregcellbio.com · Mar 2025

RegCell Raises $45.8M in Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does RegCell do?: RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.
Who are RegCell's investors?: RegCell's investors include Fast Track Initiative, Global Brain, Kyoto University Innovation Capital, UTEC, Mitsubishi UFJ Capital, OSAKA University Venture Capital.
How much funding has RegCell raised?: RegCell has disclosed $45M raised across 1 of its 2 known rounds.